OPK
OPKO Health, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$1.64
+1.86%Aug 18, 2026, 18:26 UTC
OPKO Health secured $125 million in financing against its mazdutide royalties, obtaining non-dilutive capital while retaining longer-term royalty upside.
Aug 13, 2026, 13:15 UTC
OPKO Health issued $125 million in notes to HealthCare Royalty, secured by royalty interests in Mazdutide, to raise non-dilutive capital.
Source:Aug 3, 2026, 11:00 UTC
Cocrystal Pharma announced a $5 million private placement with OPKO Health, which increased its investment in the company.
Source:Jul 27, 2026, 22:03 UTC
OPKO Health reported its second-quarter financial results, showing a narrower loss due to gains from diagnostics restructuring and a China commercialization agreement, with increased investment in clinical development.